| 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus M Aringer, K Costenbader, D Daikh, R Brinks, M Mosca, ... Arthritis & rheumatology 71 (9), 1400-1412, 2019 | 3429 | 2019 |
| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 2067 | 2019 |
| FRI0192 A SYSTEMATIC LITERATURE REVIEW TO INFORM THE 2019 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the Rheumatic Diseases 78, 773-774, 2019 | 2067* | 2019 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1282 | 2012 |
| EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including … GK Bertsias, JPA Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, ... Annals of the rheumatic diseases 67 (2), 195-205, 2008 | 1070 | 2008 |
| EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and … L Andreoli, GK Bertsias, N Agmon-Levin, S Brown, R Cervera, ... Annals of the rheumatic diseases 76 (3), 476-485, 2017 | 945 | 2017 |
| EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for … GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ... Annals of the rheumatic diseases 69 (12), 2074-2082, 2010 | 924 | 2010 |
| Treat-to-target in systemic lupus erythematosus: recommendations from an international task force RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ... Annals of the rheumatic diseases 73 (6), 958-967, 2014 | 877 | 2014 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 823 | 2020 |
| Update οn the diagnosis and management of systemic lupus erythematosus A Fanouriakis, N Tziolos, G Bertsias, DT Boumpas Annals of the rheumatic diseases 80 (1), 14-25, 2021 | 715 | 2021 |
| Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1 Y Kirino, G Bertsias, Y Ishigatsubo, N Mizuki, I Tugal-Tutkun, E Seyahi, ... Nature genetics 45 (2), 202-207, 2013 | 618 | 2013 |
| A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS) R Van Vollenhoven, A Voskuyl, G Bertsias, C Aranow, M Aringer, ... Annals of the rheumatic diseases 76 (3), 554-561, 2017 | 415 | 2017 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 414 | 2024 |
| Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 … E Stagakis, G Bertsias, P Verginis, M Nakou, M Hatziapostolou, H Kritikos, ... Annals of the rheumatic diseases 70 (8), 1496-1506, 2011 | 368 | 2011 |
| Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations GK Bertsias, DT Boumpas Nature Reviews Rheumatology 6 (6), 358-367, 2010 | 365 | 2010 |
| Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece G Bertsias, I Mammas, M Linardakis, A Kafatos BMC public health 3, 1-9, 2003 | 363 | 2003 |
| Systemic lupus erythematosus: pathogenesis and clinical features G Bertsias, R Cervera, DT Boumpas EULAR textbook on rheumatic diseases 5, 476-505, 2012 | 288 | 2012 |
| 2021 DORIS definition of remission in SLE: final recommendations from an international task force RF van Vollenhoven, G Bertsias, A Doria, D Isenberg, E Morand, MA Petri, ... Lupus science & medicine 8 (1), e000538, 2021 | 242 | 2021 |
| Expansion of toll‐like receptor 9–expressing B cells in active systemic lupus erythematosus: Implications for the induction and maintenance of the autoimmune process ED Papadimitraki, C Choulaki, E Koutala, G Bertsias, C Tsatsanis, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 241 | 2006 |
| REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A … E Frangou, A Chrysanthopoulou, A Mitsios, K Kambas, S Arelaki, ... Annals of the Rheumatic Diseases 78 (2), 238-248, 2019 | 222 | 2019 |
